Borsa Haberleri

Son finansal haberler · Güncellendi Tem 24, 2026

MSFT
▬ mixed

Microsoft’un (MSFT) Afrika Veri Merkezi Ödeme Talepleriyle Mücadele Ettiği Bildirildi, Bloomberg Haberleri

Microsoft’s (MSFT) African Data Center Struggles with Payment Requests, Bloomberg News Reports

The Kenya data center project highlights significant risks in emerging market expansion for cloud providers like Microsoft, including sovereign credit …

Yahoo Finance · May 16, 2026
P S
▬ neut…

Bu Hamleleri Yapan Yatırım Efsanelerinin Büyük Bir Hayranıyım

I’m a Big Fan of the Moves These Investment Legends Have Been Making

The panel generally agreed that while Li Lu and Pabrai's concentrated, low-turnover portfolios have historically outperformed, mimicking this strategy may …

Yahoo Finance · May 16, 2026
ANET
▬ mixed

Barclays, Arista Networks, Inc. (ANET) Hakkında Fazla Ağırlık Derecelendirmesini Koruyor

Barclays Maintains an Overweight Rating on Arista Networks, Inc. (ANET)

Arista's impressive growth and margins are supported by its dominance in data center switching and potential architectural dominance in AI …

Yahoo Finance · May 16, 2026
DAVE
▬ mixed

Keefe Bruyette, Dave Inc. (DAVE) için Outperform Derecesini Koruyor

Keefe Bruyette Maintains an Outperform Rating on Dave Inc. (DAVE)

The panelists agree that Dave Inc. has demonstrated strong Q1 results but express concerns about the sustainability of its growth …

Yahoo Finance · May 16, 2026
OLED
▬ mixed

Citi, Universal Display Corporation (OLED) Üzerindeki Nötr Görüşünü Korudu

Citi Retains Neutral Rating On Universal Display Corporation (OLED)

The panel generally agrees that OLED is facing significant challenges, including a 14% revenue contraction, 44% drop in net income, …

Yahoo Finance · May 16, 2026
CVX
▬ mixed

Chevron CEO'dan 1970'ler Tarzı Petrol Krizi Uyarısı. Yazdan Önce Yükselebilecek 3 Enerji Hissesi.

Chevron's CEO Is Warning of a 1970s-Style Oil Crisis. These 3 Energy Stocks Could Surge Before Summer.

The panel discusses the potential impacts of a Hormuz closure on oil prices and energy stocks, with mixed views on …

Yahoo Finance · May 16, 2026
▬ mixed

2026'da Evli Çiftlerin Hala Yaptığı 3 Sosyal Güvenlik Hatası

3 Social Security Mistakes Married Couples Are Still Making in 2026

While delaying the higher earner's Social Security claim to maximize survivor benefits can be mathematically sound, it exposes households to …

Yahoo Finance · May 16, 2026
R
▬ mixed

Ripple Her Hafta Banka Anlaşması Yapıyor: XRP Sahipleri Neden Fayda Görmüyor?

Ripple Is Closing Bank Deals Every Week: Why XRP Holders Aren’t Seeing the Benefit

The panel generally agrees that Ripple's success in institutional adoption and stablecoin (RLUSD) growth does not translate to XRP token …

Yahoo Finance · May 16, 2026
GAP S U
▬ mixed

Alışveriş merkezi perakende devi, 26 yıl sonra kilit bir şehirdeki son mağazasını kapatıyor

Mall retail giant closes final store in key city after 26 years

Despite positive trends like 7% Gap brand growth and 39% digital penetration, the panel is concerned about Athleta's 10% decline …

Yahoo Finance · May 16, 2026
AMD
▬ mixed

AMD Tüm Zamanların En Yüksek Seviyesine Ulaştı -- Satın Almak İçin Çok Mu Geç?

AMD Just Hit an All-Time High -- Is it Too Late to Buy?

The panel discusses AMD's record-breaking quarter, with concerns around valuation, supply chain constraints, and demand visibility. The key debate revolves …

Nasdaq · May 16, 2026
ERAS
▬ mixed

Acuta Capital, Erasca'ya (ERAS) Yatırım Yaptı ve Kanser Tedavilerini Hedefleyerek 354.575 Hissesi Satın Aldı

Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy

Despite Acuta Capital's significant investment, the panel is largely bearish due to ERAS-0015 trial's patient death, high cash burn rate, …

Nasdaq · May 16, 2026
GLP KLRA
▼ bear…

Kailera Therapeutics Satın Alınmalı mı? Halka Arz Sonrası Durumu

Is Kailera Therapeutics a Buy After Its Sizzling IPO?

Kailera Therapeutics' IPO is considered high-risk due to intense competition, lack of approved products, and substantial clinical and regulatory risks. …

Nasdaq · May 16, 2026